Middle
NIAID Launches Universal Flu Vaccine Study
A major research priority for NIAID is finding a universal flu vaccine--one that could durably protect all age groups against multiple influenza strains. NIAID has launched a new study testing a potential vaccine candidate.
Middle
Early-Stage Ebola Treatment Trial Begins
NIAID scientists are evaluating a monoclonal antibody treatment for Ebola in a Phase 1 clinical trial at the NIH Clinical Center.
Middle
10 Things to Know About HIV Suppression
Achieving and maintaining a durably undetectable viral load by taking HIV treatment as directed prevents sexual transmission of the virus to an HIV-negative partner.
